2500 studies found for:    "Schizophrenia"
Show Display Options
Rank Status Study
1 Unknown  Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Conditions: Schizophrenia, Catatonic;   Schizophrenia, Disorganized;   Schizophrenia, Paranoid;   Schizophrenia;   Psychotic Disorders
Intervention: Drug: Long-acting Risperidone microspheres injection
2 Completed
Has Results
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Interventions: Drug: asenapine 2.5 mg;   Drug: asenapine 5.0 mg;   Drug: placebo
3 Completed MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
Conditions: Paranoid Schizophrenia;   Schizophrenia
Interventions: Drug: MK0557;   Drug: Comparator: Placebo (unspecified)
4 Active, not recruiting RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)
Conditions: Schizophrenia Spectrum Disorder;   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Interventions: Behavioral: Community-based rehabilitation;   Other: Facility based care
5 Completed A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions
Conditions: Schizophrenia;   Latent Schizophrenia
Intervention:
6 Completed
Has Results
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Intervention: Drug: asenapine
7 Unknown  Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia
Conditions: Refractory Schizophrenia;   Super Refractory Schizophrenia
Interventions: Device: MECTA SPECTRUM 5000Q ECT;   Procedure: Sham ECT
8 Completed
Has Results
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
Conditions: Schizophrenia;   Schizophrenic Disorders;   Psychotic Disorders;   Dementia Praecox.
Intervention: Drug: Paliperidone ER
9 Completed
Has Results
Sodium Oxybate in Schizophrenia With Insomnia
Conditions: Schizophrenia;   Insomnia Related to Schizophrenia (307.42)
Intervention: Drug: Sodium Oxybate
10 Completed A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder
Conditions: Schizophrenia;   Schizophrenia-related Psychotic Disorder
Interventions: Drug: Placebo;   Drug: GWP42003
11 Recruiting Pregablin for Anxiety-comorbidity in Patients With Schizophrenia
Conditions: Schizophrenia;   Anxiety-comorbidity to Schizophrenia
Interventions: Drug: Pregabalin;   Drug: Pregabalin Placebo Capsules
12 Completed Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
Conditions: Schizophrenia;   Schizophrenic Disorder;   Hyperprolactinemia;   Hyperprolactinaemia
Interventions: Drug: PGD granules;   Drug: Placebo
13 Completed Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
Conditions: Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Intervention: Drug: Sarcosine and D-serine
14 Withdrawn Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
Conditions: Schizophrenias;   Psychoses;   Psychotic Disorders;   Schizophrenic Disorders
Intervention: Drug: Sarcosine (N-methylglycine)
15 Completed Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia
Condition: Schizophrenia
Intervention: Drug: N-Acetyl-Cysteine (NAC)
16 Unknown  Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
Conditions: Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder
Intervention:
17 Unknown  Trial of Cognitive Behavioral Therapy for Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder
Intervention: Behavioral: Cognitive Behavioral Therapy
18 Completed
Has Results
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition: Paranoid Schizophrenia
Interventions: Drug: MK0249;   Drug: Comparator: Placebo (unspecified)
19 Recruiting Genetic Study of Schizophrenia
Conditions: Psychotic Disorder;   Schizoaffective Disorder;   Schizophrenia
Intervention:
20 Completed Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychotic Disorder
Intervention: Drug: Risperidone/Olanzapine and PET scans

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years